and as-of-yet smaller sample sizes, such as Post-Traumatic Stress Disorder and Alcohol Dependence, have not yet attained the success achieved for Schizophrenia. However, efforts are underway to increase the number of available cases for analysis, with the expectation that once an as-of-yet-unidentified breakpoint is achieved, gene identification efforts for these disorders will follow suit.